| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -244,689 | 100% | $80.49 | -$19,695,363 |
| Net | -8 | -244,689 | -100% | -$19,695,363 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michael A. Mussallem | Director | $341,985,766 | 02 May 2024 | ||
| Scott B. Ullem | CVP, Chief Financial Officer | $24,344,557 | -$4,468,703 | -16% | 11 Mar 2026 |
| Jean-Luc M. Lemercier | CVP, EMEACLA and JAPAC | $17,050,194 | 07 Jul 2024 | ||
| Larry L. Wood | Global President TAVR & Surg | $16,163,469 | -$1,371,947 | -7.8% | 18 Aug 2025 |
| Donald E. Bobo Jr. | CVP,Strategy/Corp Development | $14,978,726 | -$6,724,372 | -31% | 02 Mar 2026 |
| Bernard J. Zovighian | CEO, Director | $8,196,627 | -$5,638,928 | -41% | 12 Feb 2026 |
| Huimin Wang | CVP, Japan & Intercontinental | $7,520,181 | 08 Jul 2022 | ||
| Catherine M. Szyman | CVP, Critical Care | $5,686,869 | 03 Sep 2024 | ||
| Steven R. Loranger | Director | $5,464,486 | 09 May 2025 | ||
| Kieran Gallahue | Director | $5,437,318 | 09 May 2025 | ||
| Nicholas J. Valeriani | Director | $5,412,744 | 09 May 2025 | ||
| Robert W.a. Sellers | SVP, Corporate Controller | $3,251,149 | 11 May 2024 | ||
| Daniel J. Lippis | Cvp, Tavr | $2,897,351 | -$716,801 | -20% | 11 Mar 2026 |
| Daveen Chopra | CVP, TMTT & Surgical | $2,716,962 | -$486,228 | -15% | 11 Dec 2025 |
| Heisz Leslie Stone | Director | $2,581,400 | -$218,120 | -7.8% | 12 Dec 2025 |
| Martha H. Marsh | Director | $2,412,360 | 12 May 2023 | ||
| Wayne Markowitz | Cvp, Japac | $1,510,582 | -$70,265 | -4.4% | 08 Dec 2025 |
| Ramona Sequeira | Director | $1,201,648 | 09 May 2025 | ||
| Annette Bruls | Cvp, Emeacla | $1,116,674 | 11 Jul 2025 | ||
| Paul A. Laviolette | Director | $976,186 | 09 May 2025 | ||
| Andrew M. Dahl | SVP, Corporate Controller | $725,158 | 22 Feb 2026 | ||
| Leslie C. Davis | Director | $449,355 | 09 May 2025 | ||
| David T. Feinberg | Director | $398,365 | 09 May 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Scott B. Ullem | EW | Common Stock | Sale | -24.7% | $1,103,896 | $84.92 | -13,000 | 39,699 | 11 Mar 2026 | Direct |
| Scott B. Ullem | EW | Common Stock | Options Exercise | 32.8% | 13,000 | 52,699 | 11 Mar 2026 | Direct | ||
| Scott B. Ullem | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -33.3% | -13,000 | 26,000 | 11 Mar 2026 | Direct | ||
| Daniel J. Lippis | EW | Common Stock | Sale | -2.92% | $87,004 | $85.38 | -1,019 | 33,934 | 11 Mar 2026 | Direct |
| Daniel J. Lippis | EW | Common Stock | Options Exercise | 3% | 1,019 | 34,953 | 11 Mar 2026 | Direct | ||
| Daniel J. Lippis | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -25% | -1,019 | 3,057 | 11 Mar 2026 | Direct | ||
| Donald E. Bobo Jr. | EW | Common Stock | Sale | -34.8% | $974,430 | $85.93 | -11,340 | 21,266 | 02 Mar 2026 | Direct |
| Donald E. Bobo Jr. | EW | Common Stock | Options Exercise | 53.3% | 11,340 | 32,606 | 02 Mar 2026 | Direct | ||
| Donald E. Bobo Jr. | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -33.3% | -11,340 | 22,680 | 02 Mar 2026 | Direct | ||
| Donald E. Bobo Jr. | EW | Common Stock | Sale | -53% | $2,012,076 | $83.84 | -24,000 | 21,266 | 25 Feb 2026 | Direct |
| Daniel J. Lippis | EW | Common Stock | Tax liability | -1.26% | -432 | 33,934 | 22 Feb 2026 | Direct | ||
| Andrew M. Dahl | EW | Common Stock | Tax liability | -1.9% | -176 | 9,089 | 22 Feb 2026 | Direct | ||
| Daniel J. Lippis | EW | Common Stock | Tax liability | -0.57% | -198 | 34,366 | 17 Feb 2026 | Direct | ||
| Scott B. Ullem | EW | Common Stock | Tax liability | -0.5% | -199 | 39,699 | 16 Feb 2026 | Direct | ||
| Daniel J. Lippis | EW | Common Stock | Tax liability | -0.74% | -258 | 34,564 | 16 Feb 2026 | Direct | ||
| Bernard J. Zovighian | EW | Common Stock | Gift | 34% | 2,920 | 11,517 | 13 Feb 2026 | By Trust | ||
| Bernard J. Zovighian | EW | Common Stock | Gift | -3.48% | -2,920 | 80,976 | 13 Feb 2026 | Direct | ||
| Daniel J. Lippis | EW | Common Stock | Award | 58.3% | 12,820 | 34,822 | 12 Feb 2026 | Direct | ||
| Bernard J. Zovighian | EW | Common Stock | Sale | -21.1% | $1,719,741 | $76.67 | -22,430 | 83,896 | 12 Feb 2026 | Direct |
| Bernard J. Zovighian | EW | Common Stock | Options Exercise | 31.3% | 25,350 | 106,326 | 12 Feb 2026 | Direct | ||
| Bernard J. Zovighian | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -100% | -25,350 | 0 | 12 Feb 2026 | Direct | ||
| Daniel J. Lippis | EW | Common Stock | Sale | -4.43% | $87,332 | $85.70 | -1,019 | 22,002 | 09 Jan 2026 | Direct |
| Daniel J. Lippis | EW | Common Stock | Options Exercise | 4.63% | 1,019 | 23,021 | 09 Jan 2026 | Direct | ||
| Daniel J. Lippis | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -20% | -1,019 | 4,076 | 09 Jan 2026 | Direct | ||
| Donald E. Bobo Jr. | EW | Common Stock | Sale | -26.2% | $971,429 | $85.66 | -11,340 | 31,870 | 06 Jan 2026 | Direct |
| Donald E. Bobo Jr. | EW | Common Stock | Options Exercise | 35.6% | 11,340 | 43,210 | 06 Jan 2026 | Direct | ||
| Donald E. Bobo Jr. | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -25% | -11,340 | 34,020 | 06 Jan 2026 | Direct | ||
| Donald E. Bobo Jr. | EW | Common Stock | Gift | -18.2% | -7,100 | 31,870 | 12 Dec 2025 | Direct | ||
| Donald E. Bobo Jr. | EW | Common Stock | Sale | -22.6% | $953,748 | $83.76 | -11,386 | 38,970 | 12 Dec 2025 | Direct |
| Daniel J. Lippis | EW | Common Stock | Sale | -4.43% | $85,625 | $84.03 | -1,019 | 22,002 | 12 Dec 2025 | Direct |
| Daniel J. Lippis | EW | Common Stock | Options Exercise | 4.63% | 1,019 | 23,021 | 12 Dec 2025 | Direct | ||
| Daniel J. Lippis | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -16.7% | -1,019 | 5,095 | 12 Dec 2025 | Direct | ||
| Heisz Leslie Stone | EW | Common Stock | Sale | -7.79% | $218,120 | $83.41 | -2,615 | 30,948 | 12 Dec 2025 | Direct |
| Daveen Chopra | EW | Common Stock | Sale | -5.85% | $168,750 | $84.38 | -2,000 | 32,201 | 11 Dec 2025 | Direct |
| Donald E. Bobo Jr. | EW | Common Stock | Sale | -18.4% | $950,581 | $83.83 | -11,340 | 50,356 | 10 Dec 2025 | Direct |
| Donald E. Bobo Jr. | EW | Common Stock | Options Exercise | 22.5% | 11,340 | 61,696 | 10 Dec 2025 | Direct | ||
| Donald E. Bobo Jr. | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -20% | -11,340 | 45,360 | 10 Dec 2025 | Direct | ||
| Bernard J. Zovighian | EW | Common Stock | Sale | -31% | $322,367 | $83.45 | -3,863 | 8,597 | 10 Dec 2025 | By Trust |
| Bernard J. Zovighian | EW | Common Stock | Gift | 44.9% | 3,863 | 12,460 | 09 Dec 2025 | By Trust | ||
| Bernard J. Zovighian | EW | Common Stock | Gift | -4.55% | -3,863 | 80,976 | 09 Dec 2025 | Direct | ||
| Scott B. Ullem | EW | Common Stock | Sale | -16.2% | $650,412 | $84.47 | -7,700 | 39,898 | 09 Dec 2025 | Direct |
| Scott B. Ullem | EW | Common Stock | Options Exercise | 19.3% | 7,700 | 47,598 | 09 Dec 2025 | Direct | ||
| Scott B. Ullem | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -16.5% | -7,700 | 39,000 | 09 Dec 2025 | Direct | ||
| Bernard J. Zovighian | EW | Common Stock | Sale | -20.2% | $1,831,006 | $85.21 | -21,487 | 84,839 | 08 Dec 2025 | Direct |
| Bernard J. Zovighian | EW | Common Stock | Options Exercise | 31.3% | 25,350 | 106,326 | 08 Dec 2025 | Direct | ||
| Bernard J. Zovighian | EW | Employee Stock Option (Right to Acquire) | Options Exercise | -50% | -25,350 | 25,350 | 08 Dec 2025 | Direct | ||
| Wayne Markowitz | EW | Common Stock | Sale | -3.21% | $50,144 | $86.01 | -583 | 17,563 | 08 Dec 2025 | Direct |
| Andrew M. Dahl | EW | Common Stock | Award | 14.5% | 1,160 | 9,183 | 13 Nov 2025 | Direct | ||
| Scott B. Ullem | EW | Common Stock | Sale | -24.6% | $1,080,093 | $83.08 | -13,000 | 39,898 | 10 Nov 2025 | Direct |
| Scott B. Ullem | EW | Common Stock | Options Exercise | 32.6% | 13,000 | 52,898 | 10 Nov 2025 | Direct |